ClassID:

91946

C07C59/54 - CPC Classification

Classification description:

Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups; Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings and other rings

Recent Application in this class:
#1
20260055046
2026-02-26

MODULATORS OF LIVER RECEPTOR HOMOLOGUE 1 (LRH-1) AND USES

#2
20260035353
2026-02-05

PHENOL DERIVATIVES FOR USE AS ANTIMICROBIAL, ANTIBACTERIAL, BACTERICIDE

#3
20250361197
2025-11-27

Series of Compounds for Treatment of Skin Diseases and Other Conditions

#4
20240391865
2024-11-28

COMPOUNDS FOR THE TREATMENT OF ACUTE BRAIN INJURY

#5
20240368066
2024-11-07

MODULATORS OF LIVER RECEPTOR HOMOLOGUE 1 (LRH-1) AND USES

#6
20230295070
2023-09-21

Modulators of liver receptor homologue 1 (LRH-1) and uses

#7
20220411356
2022-12-29

Series of Compounds for Treatment of Skin Diseases and Other Conditions

#8
20220281835
2022-09-08

PHENOL DERIVATIVES FOR USE AS ANTIMICROBIAL, ANTIBACTERIAL, BACTERICIDE

#9
20210395175
2021-12-23

HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

#10
20210122700
2021-04-29

Compounds for the treatment of acute brain injury

#11
20210047258
2021-02-18

Modulators of liver receptor homologue 1 (LRH-1) and uses

#12
20200407336
2020-12-31

Treprostinil derivative compounds and methods of using same

#13
20200189999
2020-06-18

CYCLOALKYL-HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

#14
20200131108
2020-04-30

Method for synthesizing novel compounds derived from 3-hydroxy-cylopentyl acetic acid

#15
20200115307
2020-04-16

Series of compounds for treatment of skin diseases and other conditions

#16
20200017433
2020-01-16

Modulators of liver receptor homologue 1 (LRH-1) and uses

#17
20190292163
2019-09-26

Treprostinil derivative compounds and methods of using same

#18
20190263742
2019-08-29

Hydroxyl compounds and compositions for cholesterol management and related uses

#19
20190084908
2019-03-21

CYCLOALKYL-HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

#20
20180086730
2018-03-29

Treprostinil derivative compounds and methods of using same

#21
20180072682
2018-03-15

Compositions for the treatment of fibrosis and fibrosis-related conditions

#22
20180065912
2018-03-08

Methods of treating Parkinson's disease

#23
20180057440
2018-03-01

Method for synthesizing novel compounds derived from 3-hydroxy-cyclopentyl acetic acid

#24
20180015051
2018-01-18

MODULATORS OF ALPHA-DICARBONYL DETOXIFICATION AND THEIR USE FOR THE TREATMENT OF DIABETIC PATHOLOGIES

#25
20170349516
2017-12-07

Hydroxyl compounds and compositions for cholesterol management and related uses

#26
20170183326
2017-06-29

Cocrystal, production method thereof, and medicament containing cocrystal

#27
20170182046
2017-06-29

Therapeutic compounds

#28
20170073286
2017-03-16

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#29
20160368889
2016-12-22

Treprostinil derivative compounds and methods of using same

#30
20160340279
2016-11-24

Substituted (4'-hydroxyphenyl)cyclohexane compounds and uses thereof as selective agonists of the estrogen receptor beta isoform

#31
20160200703
2016-07-14

Specific inhibitors of cytochrome P450 26 retinoic acid hydroxylase

#32
20160175269
2016-06-23

Crystalline forms of bimatoprost acid, methods for preparation, and methods for use thereof

#33
20150344389
2015-12-03

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#34
20150344388
2015-12-03

Hydroxyl compounds and compositions for cholesterol management and related uses

#35
20150313856
2015-11-05

Compounds and compositions for the treatment of cancer

#36
20150126574
2015-05-07

Atrasentan mandelate salts

#37
20150073031
2015-03-12

Atrasentan mandelate salts

#38
20140343079
2014-11-20

Therapeutic compounds

#39
20140275236
2014-09-18

Anti-neurodegenerative natural compound isolated from alpiniae oxyphyllae fructose and their total synthesis

#40
20140256730
2014-09-11

Treprostinil derivative compounds and methods of using same

#41
20140235723
2014-08-21

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#42
20140187637
2014-07-03

Tromethamine salt of bimatoprost acid in crystalline form, methods for preparation, and methods for use thereof

#43
20140187636
2014-07-03

Crystalline forms of bimatoprost acid, methods for preparation, and methods for use thereof

#44
20130289117
2013-10-31

Hydroxyl compounds and compositions for cholesterol management and related uses

#45
20130217645
2013-08-22

Compounds and compositions for the treatment of cancer

#46
20130040916
2013-02-14

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#47
20120238581
2012-09-20

Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme

#48
20120225908
2012-09-06

Hydroxyl compounds and compositions for cholesterol management and related uses

#49
20120172337
2012-07-05

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#50
20120035141
2012-02-09

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

#51
20120016158
2012-01-19

Loxoprofen derivative and pharmaceutical preparation containing the same

#52
20120015443
2012-01-19

Chiral selectors and stationary phases for separating enantiomer mixtures

#53
20110060146
2011-03-10

VITAMIN-D-LIKE COMPOUNDS

#54
20110034528
2011-02-10

Elansolids, Novel Natural Metabolites of Flexibacter and Antibiotically Active Derivatives Thereof

#55
20110003860
2011-01-06

HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES

#56
20100204199
2010-08-12

Cyclic 11-beta hydroxysteroid dehydrogenase type 1 inhibitors

#57
20090253659
2009-10-08

Cycloalkylidene compounds as modulators of estrogen receptor

#58
20090247489
2009-10-01

Dihydroxyl compounds and compositions for cholesterol management and related uses

#59
20090229352
2009-09-17

Chiral selectors and stationary phases for separating enantiomer mixtures

#60
20090137609
2009-05-28

Vitamin D-like compound

#61
20080249166
2008-10-09

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management

#62
20080234249
2008-09-25

Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors

#63
20080194565
2008-08-14

5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases

#64
20080182861
2008-07-31

Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme

#65
20080064661
2008-03-13

Dihydroxyl compounds and compositions for cholesterol management and related uses

#66
20080021088
2008-01-24

Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities

#67
20070213348
2007-09-13

Cycloalkylidene compounds as modulators of estrogen receptor

#68
20070179120
2007-08-02

Hydroxyl compounds and compositions for cholesterol management and related uses

#69
20070155839
2007-07-05

Cycloalkylidene compounds as modulators of estrogen receptor

#70
20070082954
2007-04-12

Pharmaceutical compositions containing (+) cannabidioil and derivatives thereof and some such novel derivatives

#71
20060229281
2006-10-12

Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses

#72
20060160875
2006-07-20

Matrix metalloproteinase inhibitors

#73
20050267183
2005-12-01

Selective estrogen receptor modulators

#74
20050245602
2005-11-03

Selective estrogen receptor modulators

#75
20050192449
2005-09-01

Compounds with hydroxycarbonyl-halogenoalkyl side chains

#76
20050043278
2005-02-24

Hydroxyl compounds and compositions for cholesterol management and related uses

#77
20050038123
2005-02-17

Process and intermediates to prepare latanoprost